Tilray Didn’t Announce Its Last Quarter. The Numbers Weren’t Great.

Tilray Didn’t Announce Its Last Quarter. The Numbers Weren’t Great.
·2 min read

Without fanfare, (TLRY) filed financial results from its last quarter as a stand-alone business, before its May 3 merger with cannabis rival Aphria. As it happens, those March quarter results weren’t much to write home about. The decline was in Tilray’s sales of hemp, the nonintoxicating variety of cannabis that Congress legalized in 2018—with high hopes and disappointing results for businesses that bet on the hemp-derived ingredient known as CBD.

Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting